Incoming SNSF Ambizione group leader at EPFL. Interested in bacteria-host interactions in health and disease.

Zurich, Switzerland
Joined October 2009
Excited to announce my upcoming @snsf_ch Ambizione research group at @EPFL_en on bacteria-host interactions, combining systems approaches and microphysiological models. 🚨 We have an open PhD position! More info on projects and how to apply here: elisabettacacace.github.io/B…
2
3
2
15
1,895
Elisabetta Cacace retweeted
🚨🔬Excited to share our new paper now out in @NatureMicrobiol! Using Tn-seq + live imaging in engineered airway organoids, we explored the fitness tradeoffs P. aeruginosa faces while growing and surviving antibiotic treatment on the mucosal surface. 🔗 rdcu.be/dX4RR
8
20
2
96
13,319
Exciting news! @HausmannAnnika will be joining the Mucosal immunology team @ETH in November as a junior group leader to establish a group working in microbiota-epithelial crosstalk. Fully funded PhD position available! Please RT jobs.ethz.ch/job/view/JOPG_e…
4
28
2
84
8,068
Elisabetta Cacace retweeted
I was asked by @NatureSMB to write a commentary on the future of structural biology which I am unsure about. I wrote about collaborative research instead. It is not open access but it can be read via this link rdcu.be/dNOLS
24
4
98
15,310
Elisabetta Cacace retweeted
Do you want to run a microbial GWAS but are put off by installing a dozen different bioinformatic tools, are unsure about best practices, and how to transform the list of threshold passing variants into a neat annotated table? Then we have just the thing for you!
New preprint now online 🥳 We have developed a pipeline to perform bacterial GWAS from a set of assemblies and annotations, with one or multiple phenotypes as targets.
1
52
1
144
20,487
Elisabetta Cacace retweeted
The lab is recruiting (postdoc level) 👇 Join us: we love good science and there is a great team spirit 💫 clavel.ukaachen.de; ukaachen.de/stellenangebote/…
2
77
3
100
24,682
Elisabetta Cacace retweeted
Inspiring essay by Roberto Kolter. This should be taught before university: knowing how to ask the right questions, the ones we're interested in, not just those for a 'good' paper. This makes a good researcher, IMO. journals.asm.org/doi/10.1128…
1
12
36
4,352
Excited to present my latest work today at #nacarb2024 in Ascona!
16
521
This started from the serendipitous observation of NX low MIC (1-4 µg/ml) on A. baumannii, critical priority pathogen according to WHO. A breakpoint is available only for E. coli, so let's fix that! We tested NX MICs on > 1,000 isolates from > 30 Gram- species with 3 methods.
1
1
2
394
This started as one of my periodic forays into clinical micro - great collab between @goetheuni and @EMBL. Many thanks to the Göttig group, especially co-first Manuela Tietgen, @TypasLab, @ESRF_FR and everyone involved.
1
1
138
Take-home message: it makes sense to look back and revisit our current antibiotic arsenal with systems approaches and most importantly new eyes.
1
125
TL;DR 1) NX known since '70s but very limited use 2) cidal against A. baumannii 3) synergy w/ atbs only active on Gram+ (vanco) 4) resensitizes colistin-R Enterobacteriaceae 5) perturbs OM and induces Cu and Zn overload 6) resistance based on RND pump regulators across species.
1
3
187